NATAP: Smoking Cessation Drugs Safety

[Guest guest]

Smoking Cessation Drugs SafetyFDA Drug Safety Communication: Chantix (varenicline) may ...www.natap.org/2011/newsUpdates/062011_05.htm[6-16-2011] The U.S. Food and Drug Administration (FDA) is notifying the public that the smoking cessation aid Chantix (varenicline) may be associated with a ...Chantix, Quit-Smoking Drug, Safety Concerns, Pfizer defends ...www.natap.org/2011/newsUpdates/070711_04.htmJul 5, 2011 – FDA Drug Safety Communication: Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with ...Chantix (varenicline): Label Change - Risk of Certain ...www.natap.org/2011/newsUpdates/072311_02.htm[uPDATED 07/22/2011] FDA has approved an updated drug label for Chantix (varenicline) to include information about the efficacy and safety of the drug in two ...Chantix Smoking Cessation Treatment Linked to Heart Disease Risk ...www.natap.org/2011/newsUpdates/071811_01.htmJun 1, 2011 – FDA Drug Safety Communication: Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with ...Increased CV risk with smoking cessation drug varenicline: New ...www.natap.org/2011/newsUpdates/070711_01.htmSingh notes that while 1 in 10 people on Chantix quit smoking, the number ... He added: "We don't know if the cardiovascular risk with Chantix stops after the ...